Atlas Trials

Incyte Biosciences International Sàrl

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Incyte Biosciences International Sàrl

RecordFirmDate
INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT05359692)Incyte Biosciences International Sàrl2023-03-01
Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT05287113)Incyte Biosciences International Sàrl2022-11-14
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors (NCT03934372)Incyte Biosciences International Sàrl2020-01-29
A Study to Evaluate Effectiveness and Safety of Ponatinib in Patients With BCR-ABL Positive ALL in Standard Clinical Practice in Europe - "POSEIDON" (NCT03515785)Incyte Biosciences International Sàrl2018-12-31
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies (NCT03538028)Incyte Biosciences International Sàrl2018-06-18
INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies (NCT03277352)Incyte Biosciences International Sàrl2017-11-21
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies (NCT03241173)Incyte Biosciences International Sàrl2017-10-09

Track Incyte Biosciences International Sàrl automatically

Every clearance here is in the API, with alerts when new ones post.